Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per the on-going reports about 4 Journals, 7 Conferences, 162 National symposiums are presently dedicated to Experimental Study and 96 Open access journals are being published on Experimental Study.
Experimental Study Unlike a descriptive study, an experiment is a study in which a treatment, procedure, or program is intentionally introduced and a result or outcome is observed. The American Heritage Dictionary of the English Language defines an experiment as “A test under controlled conditions that is made to demonstrate a known truth, to examine the validity of a hypothesis, or to determine the efficacy of something previously untried.”
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe and Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Most experimental studies allocate and compare treatments between individual subjects, but it is also possible to carry out experimental interventions at the level of populations. We have already cited a coronary heart disease prevention project in which the units of study were the workforces of different factories. As in studies of individuals, interventions in populations can be randomly allocated. However, if the number of populations under comparison is small then randomisation may not be of much value. Instead, it may be better to assign interventions in a deliberately planned way to ensure maximum comparability between different intervention groups. Control of residual confounding can be strengthened by comparing study and control populations before and after the intervention is introduced. Like longitudinal studies, experimental investigations tend to be time consuming and expensive. They should not, therefore, be undertaken without good reason. However, if well designed and conducted, they do provide the most compelling evidence of cause and effect.
2nd Applied Microbiology Conference
October 31- November 2, 2016 Istanbul, Turkey
Human Papillomavirus Conference
May 2-3, 2016 Chicago, USA
Oct 27-28, 2016 Chicago, USA
March 29-30, 2016 Valencia, Spain
Sept 12-14, 2016 San Antonio, USA
Medical Parasitology Conference,
Oct 17-19, 2016 Houston, USA
5th Virology Conference,
Dec 1-3, 2016, Baltimore, USA
2nd Influenza Conference
Sept 12-14, 2016 Berlin, Germany
2nd Parasitology Conference
Oct 10-12, 2016 Manchester, UK
6th Euro Virology Conference
March 10-12, 2016 Madrid, Spain
2nd Flu Conference
Nov 17-19, 2016 San Francisco, USA
3rd Chronic Obstructive Pulmonary Disease (COPD) Conference
July 11-12, 2016 Brisbane, Australia
European Infectious Diseases Conference,
Aug 1-3, 2016 Frankfurt, Germany
List of Related Societies
American society for Micro Biology
Society for General Micro Biology
Swiss Society for Micro Biology
Society for applied Microbiology
International Union of Microbiological societies
Federation of European Microbiological Societies
Sociedad Española de Microbiología (Spanish Society for Microbiology, SEM)
Scandinavian Society of Antimicrobial Chemotherapy (SSAC)
Svenska föreningen för mikrobiologi (Swedish Society for Microbiology, SFM)
Swedish Society of Infectious Diseases
Swedish Society of Medical Microbiology
Swiss Society for Infectious Disease
Society for General Microbiology (SGM)
British Infection Association
British Society for Antimicrobial Chemotherapy (BSAC)
Society for Applied Microbiology (SfAM)
The Hospital Infection Society
Scottish Microbiology Society
Welsh Microbiological Association (WMA)
List of Related Companies
Gilead Sciences, Inc.
Biogen Idec, Inc.
Regeneron Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc.
BioMarin Pharmaceutical, Inc.
Agilent Technologies, Inc.
ALTEK Information Technology
This page will be updated regularly.
This page was last updated on January 20, 2021